Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor - A case report

Endocrine Practice

Volumn 19, Issue 1, 2013, Pages

  Gonzales, Michael C ^a   Lieb, David C ^b   Richardson, Donald W ^b   O'Brian, John T ^b   Aloi, Joseph A ^b   Khardori, Romesh K ^b  

^a Hattiesburg Clinic   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM SENSING RECEPTOR; ERGOCALCIFEROL; GLUCONATE CALCIUM; HYDROCHLOROTHIAZIDE; MAGNESIUM; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHORUS; RECOMBINANT PARATHYROID HORMONE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; ENDOCRINOLOGY; FEMALE; FINGER; GAIN OF FUNCTION MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; LABORATORY TEST; LEG MUSCLE; LIP; MEDICAL HISTORY; PARESTHESIA; GENETICS; MIDDLE AGED; MUTATION; TREATMENT OUTCOME;

FEMALE; HUMANS; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; MIDDLE AGED; MUTATION; PARATHYROID HORMONE; RECEPTORS, CALCIUM-SENSING; TREATMENT OUTCOME;

EID: 84881500575     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12132.CR     Document Type: Article

References (22)

1. Shoback DM. Hypoparathyroidism. N Engl J Med. 2008;359:391-403.
2. Brindzjuk M, Krupp G, Kettritz Ute, et al. Physician induced hypocalcemia, nephrocalcinosis and incomplete distal renal tubular acidosis. Nephrol Dial Transplant. 2000;15:1248-1250 (Pubitemid 30487809)
3. Chou Y-H, Brown EM, Levi T, et al. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3 in four unrelated families. Nature Genetics. 1992;1:295-300.
4. Pin JP, Galvez T, Prézeau L. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther. 2003;98:325-354. (Pubitemid 36638547)
5. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev. 2001;81:239-297. (Pubitemid 32096177)
6. Pearce SHS, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med. 1996;335:1115-1122. (Pubitemid 26330965)
7. Ritter CS, Pande S, Krits I, Slatopolsky E, Brown AJ. Destabilization of parathyroid hormone mRNA by extracellular Ca2- and the calcimimetic R-568 in parathyroid cells: role of cytosolic Ca and requirement for gene transcription. J Mol Endocrinol. 2008;40:13-21. (Pubitemid 351279505)
8. Handlogten ME, Huang C, Shiraishi N, Awata H, Miller RT. The Ca2--sensing receptor activates cytosolic phospholipase A2 via a Gq-dependent ERK-independent pathway. J Biol Chem. 2001;276:13941-13948.
9. Lovlie R, Eiken HG, Sorheim JI, Boman H. The Ca2+-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Hum Genet. 1996;98:129-133. (Pubitemid 26237488)
10. Hoff AO, Cote GJ, Fritsche HA Jr, Qiu H, Schultz PN, Gagel RF. Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. Neoplasia. 1999;1:485-491.
11. Pearce SHS, Bai M, Quinn SJ, Kifor O, Brown EM, Thakker RV. Functional characterization of calcium-sensing receptor mutations expressed in human hmbryonic kidney cells. J Clin Invest. 1996;98:1860-1866. (Pubitemid 26359204)
12. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Hum Mutat. 2000;16:281-296.
13. Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcemia caused by a Ca2+-sensing receptor gene mutation. Nat Genet. 1994;8:303-307.
14. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med. 1999;106: 238-253. (Pubitemid 29115966)
15. Suzuki M, Aso T, Sato T, et al. A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection. Clin Nephrol. 2005;63:481-486. (Pubitemid 40872628)
16. Sato K, Hasegawa Y, Nakae J, et al. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab. 2002;87:3068-3073. (Pubitemid 34816346)
17. Bilezikian JP, Khan A, Potts J, et al. Hypoparathyroidism in the adult: Epidemiology, fiagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future Rresearch. J Bone Miner Res. 2011;26:2317-2337.
18. Mittelman SD, Hendy GN, Fefferman RA, Canaff L, et al. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab. 2006;91:2474-2479. (Pubitemid 44024602)
19. Winer KK, Ko CW, Reynolds JC, et al. Long-term treatment of hypoparathyroidism: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab. 2003;88: 4214-4220. (Pubitemid 37153722)
20. Theman TA, Collins, MT, Dempster DW, et al. PTH (1-34) Replacement therapy in a child with Hypoparathyroidism Caused by a Sporadic Calcium Receptor Mutation. J Bone Mineral Res. 2009;24:964-973.
21. Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP. Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporosis Int. 2010;21:1927-1934.
22. Rubin MR, Dempster DW, Sliney J Jr, et al. PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Mineral Res. 2011;26:2727-2736.